全球鼻插管市场：市场规模、份额、成长分析 - 按类型、应用、产业预测（2024-2031）

Global Nasal Cannula Market Size, Share, Growth Analysis, By Type(Low Flow and high flow), By Application(Hospitals, ambulatory health services) - Industry Forecast 2024-2031

出版日期: 2024年03月06日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球鼻插管市场规模将达72.4亿美元，2023年将达到76.5亿美元，2024-2031年预测期间复合年增长率为6.4%，2031年将达到11.8亿美元，预计将达到2000万美元。

近年来，全球鼻插管市场经历了显着的成长和进步。鼻插管是一种广泛使用的医疗设备，在为呼吸困难或需要呼吸辅助的患者提供补充氧气方面发挥重要作用。市场动力受到多种因素的推动，包括慢性阻塞性肺病（COPD）、气喘和睡眠呼吸中止症等呼吸系统疾病盛行率的上升。此外，人口老化、医疗保健支出增加以及家庭医疗保健服务需求的快速增长是市场扩张的进一步推动力。

不断的技术进步带来了创新的鼻插管，这些插管具有更高的舒适度、卓越的氧气输送效率和更高的患者依从性。此外，COVID-19 大流行的爆发扩大了对鼻插管的需求，特别是在患有呼吸道併发症的患者中。

市场格局的特点是存在许多积极从事研发以推出先锋产品并保持竞争力的主要企业。由于呼吸道疾病的高发病率和有利的报销政策，北美传统上主导全球鼻插管市场，但亚太地区预计在预测期内将大幅成长。这一增长将由医疗基础设施的扩大、对呼吸系统疾病的认识的提高以及获得医疗服务的机会的增加所推动。

综上所述，由于技术进步、呼吸系统疾病发病率上升以及对有效呼吸护理解决方案的需求不断增长，预计全球鼻插管市场在可预见的未来将保持上升趋势。

Allied Healthcare Products, Inc.（US）
Teleflex Incorporated（US）
Flexicare Medical Ltd.（UK）
Vapotherm Inc.（US）
ResMed Inc.（US）
Fairmont Medical（Australia）
Fisher & Paykel Healthcare Limited（New Zealand）
Well Lead Medical Co. Ltd.（China）
Salter Labs（US）
Hamilton Medical AG（Switzerland）
Drive DeVilbiss Healthcare（US）
Vygon（France）
Besmed Health Business Corp.（Taiwan）
Smiths Medical（UK）
Great Group Medical Co. Ltd.（Taiwan）
MAQUET Holding BV & Co. KG（Germany）
Flexicare Medical（US）
Progetti Srl（Italy）
Pulmodyne（US）
GALEMed Corporation（Taiwan）

简介目录

Product Code: SQMIG35A2292

Global Nasal Cannula Market size was valued at USD 7.24 billion in 2022 and is poised to grow from USD 7.65 billion in 2023 to USD 11.82 billion by 2031, growing at a CAGR of 6.4% during the forecast period (2024-2031).

In recent years, the global market for nasal cannulas has experienced notable growth and advancements. Nasal cannulas, widely utilized medical devices, play a crucial role in delivering supplemental oxygen to patients encountering respiratory difficulties or necessitating respiratory support. The market's momentum is propelled by various factors, including the escalating prevalence of respiratory ailments like chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea. Moreover, an aging population, augmented healthcare spending, and the surging demand for home healthcare services further fuel market expansion.

Continuous technological progress has resulted in the emergence of innovative nasal cannulas boasting enhanced comfort, superior oxygen delivery efficiency, and improved patient adherence. Furthermore, the onset of the COVID-19 pandemic has amplified the requirement for nasal cannulas, particularly among patients grappling with respiratory complications.

The market landscape is characterized by the presence of numerous key players actively involved in research and development initiatives to introduce pioneering products and maintain a competitive stance. While North America has traditionally dominated the global nasal cannula market, owing to its high prevalence of respiratory ailments and favorable reimbursement policies, the Asia Pacific region is poised for significant growth in the forecast period. This growth is fueled by the expanding healthcare infrastructure, heightened awareness regarding respiratory diseases, and enhanced access to healthcare services.

In summary, the global nasal cannula market is anticipated to sustain its upward trajectory in the foreseeable future, driven by advancements in technology, escalating respiratory disorders, and the escalating demand for effective respiratory care solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nasal Cannula Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nasal Cannula Market Segmental Analysis

There are three segments in the global nasal cannula market: type, application, and geography. The market can be divided into Low Flow and High Flow segments based on type. The market is divided into segments according to application, including long-term care facilities, hospitals, and ambulatory health services. The market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America based on geographic factors.

Drivers of the Global Nasal Cannula Market

The rising incidence of respiratory illnesses is one of the major factors propelling the worldwide nasal cannula market. The need for respiratory support and oxygen therapy is increasing due to the increased prevalence of diseases like chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea worldwide. This is propelling the expansion of the nasal cannula market.

Restraints in the Global Nasal Cannula Market

The existence of substitute respiratory support equipment is a major commercial barrier. Although nasal cannulas are a common and useful tool, there are more sophisticated respiratory support alternatives available with mechanical ventilators and non-invasive ventilation (NIV) devices. Depending on how severe their respiratory disease is, certain patients might need these other devices, which in some circumstances could limit the nasal cannula market's potential for growth.

Market Trends of the Global Nasal Cannula Market

The growing use of high-flow nasal cannulas is a significant industry trend in the nasal cannula market globally. Patients with severe respiratory disorders can benefit from enhanced oxygenation and respiratory support thanks to high-flow nasal cannulas, which give a much higher flow rate of oxygen. The increased awareness of the advantages provided by high-flow nasal cannulas-such as increased patient comfort, less respiratory effort, and enhanced inspired air humidification-is what is causing this trend. The market for nasal cannulas is growing generally because more and more high-flow nasal cannulas are being used in different healthcare settings, such as emergency rooms, intensive care units, and hospitals.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Nasal Cannula Market by Type

Market Overview
Low Flow and high flow

Global Nasal Cannula Market by Application

Market Overview
Hospitals
ambulatory health services
long term care centres and others

Global Nasal Cannula Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Allied Healthcare Products, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Flexicare Medical Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vapotherm Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ResMed Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fairmont Medical (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fisher & Paykel Healthcare Limited (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Well Lead Medical Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Salter Labs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Medical AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Drive DeVilbiss Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vygon (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Besmed Health Business Corp. (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smiths Medical (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Great Group Medical Co. Ltd. (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MAQUET Holding B.V. & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Flexicare Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Progetti S.r.l. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pulmodyne (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GALEMed Corporation (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments